Skip to main content
Log in

Universal HAV/HBV vaccination worth extra cost in HCV infection

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Jakiche R, Borrego ME, Raisch DW, Gupchup GV, Pai MA, Jakiche A.The cost-effectiveness of two strategies for vaccinating U.S. veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses. American Journal of the Medical Sciences 333: 26-34, No. 1, Jan 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Universal HAV/HBV vaccination worth extra cost in HCV infection. Pharmacoecon. Outcomes News 524, 12 (2007). https://doi.org/10.2165/00151234-200705240-00032

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705240-00032

Keywords

Navigation